ARCHIVES

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

New Group Review First NTP Reports, Gets Job On Permanent Basis, Wrangles Over Extrapolation

July 11, 1980

RFA: Native American Women’s Cancer Initiative

July 9, 1993

Low Adiponcetin Hormone Levels Linked to Increased Cancer Risk

January 25, 2013

Ohio State to study center expansion.

September 26, 2003

FY’78 Construction Requests $44 Million, Budget At $12 Million

December 2, 1977

Prostate Cancer Prevention Trial Begins At 222 U.S. Sites

October 22, 1993